CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (447,770)	$ (1,109,406)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	25,101	35,519
Amortization of debt discount on notes payable	2,783	2,148
Amortization of right of use assets	17,046	21,512
Share-based payment compensation	5,331	8,184
Recovery of returns and doubtful accounts	33,695	(18,740)
Changes in operating assets and liabilities:
Accounts receivable	452,374	2,044,122
Prepaid expenses and other current assets	(141,566)	(222,019)
Contract assets	28,628	13,120
Inventory	0	7,667
Other assets	63,516	5,437
Accounts payable	65,293	389,847
Accrued expenses and other long-term liabilities	(204,083)	(259,405)
Operating lease liabilities	(17,046)	(21,512)
Deferred revenue	28,348	(682,055)
Net cash provided by (used in) operating activities	(88,350)	214,419
Cash flows from investing activities:
Purchases of property and equipment	(2,898)	0
Net cash provided by (used in) investing activities	(2,898)	0
Cash flows from financing activities:
Cash Paid for Payroll Taxes on Restricted Stock Unit Release	(681)	0
Payments of short-term debt	(75,921)	0
Net cash provided by (used in) financing activities	(76,602)	0
Effect of exchange rate changes on cash and cash equivalents	(3,985)	(13,989)
Net increase (decrease) in cash and cash equivalents	(171,835)	200,430
Cash and cash equivalents, beginning of period	2,011,062	3,181,209
Cash and cash equivalents, end of period	1,839,227	3,381,639
Supplemental disclosures:
Cash paid for interest	46,746	21,554
Non-cash investing and financing activities:
Undistributed Series A redeemable convertible preferred stock dividends	315,215	300,921
Accretion of Series A redeemable convertible preferred stock	$ 9,851	$ 14,815